HK1186767A1 - 用於分析受試者血樣中疾病標記物的存在的方法 - Google Patents

用於分析受試者血樣中疾病標記物的存在的方法

Info

Publication number
HK1186767A1
HK1186767A1 HK13114039.9A HK13114039A HK1186767A1 HK 1186767 A1 HK1186767 A1 HK 1186767A1 HK 13114039 A HK13114039 A HK 13114039A HK 1186767 A1 HK1186767 A1 HK 1186767A1
Authority
HK
Hong Kong
Prior art keywords
analysing
subject
blood sample
disease marker
marker
Prior art date
Application number
HK13114039.9A
Other languages
English (en)
Inventor
托馬斯.武丁格爾
羅爾夫.喬納斯.尼爾松
Original Assignee
阿姆斯特丹自由大學及阿姆斯特丹自由大學醫療中心基金會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿姆斯特丹自由大學及阿姆斯特丹自由大學醫療中心基金會 filed Critical 阿姆斯特丹自由大學及阿姆斯特丹自由大學醫療中心基金會
Publication of HK1186767A1 publication Critical patent/HK1186767A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13114039.9A 2010-07-16 2013-12-18 用於分析受試者血樣中疾病標記物的存在的方法 HK1186767A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36483110P 2010-07-16 2010-07-16
EP10169897 2010-07-16
EP11158912 2011-03-18
EP11167973 2011-05-27
PCT/NL2011/050518 WO2012008839A2 (en) 2010-07-16 2011-07-15 A method of analysing a blood sample of a subject for the presence of a disease marker

Publications (1)

Publication Number Publication Date
HK1186767A1 true HK1186767A1 (zh) 2014-03-21

Family

ID=45469975

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13114039.9A HK1186767A1 (zh) 2010-07-16 2013-12-18 用於分析受試者血樣中疾病標記物的存在的方法

Country Status (11)

Country Link
US (1) US10174364B2 (zh)
EP (1) EP2593787B1 (zh)
JP (2) JP6076901B2 (zh)
CN (1) CN103168235B (zh)
AU (1) AU2011277178B2 (zh)
BR (1) BR112013001136B1 (zh)
CA (1) CA2805586C (zh)
HK (1) HK1186767A1 (zh)
MX (1) MX351242B (zh)
SG (1) SG187101A1 (zh)
WO (1) WO2012008839A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351242B (es) 2010-07-16 2017-10-05 Stichting Vu Vumc Star Un metodo para analizar una muestra de sangre de un sujeto por la presencia de un marcador de enfermedad.
CA2830461C (en) * 2011-03-18 2021-06-29 Thomas Wurdinger A method of analysing a blood sample of a subject for the presence of a disease marker
AU2013274016A1 (en) * 2012-06-15 2015-01-22 Autotelic Llc Methods and compositions for personalized medicine by point-of-care devices for FSH, LH, HCG and BNP
WO2014134790A1 (zh) * 2013-03-06 2014-09-12 广州百赫医疗信息科技有限公司 神经纤维瘤病pcr诊断试剂盒
CA2944903A1 (en) * 2014-04-24 2015-10-29 Dana-Farber Cancer Institute, Inc. Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
US10512402B2 (en) * 2015-04-22 2019-12-24 Board Of Trustees Of Northern Illinois University Non-invasive occular biomarkers for early diagnosis of diseases
EP3494235A1 (en) * 2017-02-17 2019-06-12 Stichting VUmc Swarm intelligence-enhanced diagnosis and therapy selection for cancer using tumor- educated platelets
US11667975B2 (en) * 2018-04-24 2023-06-06 Washington University Methods and systems for noninvasive and localized brain liquid biopsy using focused ultrasound
CN112094907B (zh) * 2019-06-18 2023-08-18 杭州太铭生物科技有限公司 外周血红细胞微核dna及其应用
CN113430264A (zh) * 2020-03-23 2021-09-24 南京梅傲红清生物科技有限公司 红细胞核酸在鉴定肿瘤的突变类型中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
US5185244A (en) 1989-12-08 1993-02-09 Emory University Genetic test for hereditary neuromuscular disease
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US5719028A (en) 1992-12-07 1998-02-17 Third Wave Technologies Inc. Cleavase fragment length polymorphism
SE9400522D0 (sv) 1994-02-16 1994-02-16 Ulf Landegren Method and reagent for detecting specific nucleotide sequences
US5942391A (en) 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
CA2370884A1 (en) 1999-04-20 2000-10-26 Mitokor Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
US7741029B2 (en) * 2001-03-07 2010-06-22 Andre Schuh Diagnosis and treatment of blood disorders
GB2380194B (en) * 2001-10-01 2005-06-22 Roger Michael Marchbanks A mitochondrial mutation associated with schizophrenia and increased oxidative stress
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
EP1706720A4 (en) 2003-10-31 2007-02-28 Vitatex Inc BLOOD TEST PROTOTYPES AND METHOD FOR DETECTING CIRCULATING TUMOR AND ENDOTHELIAL CELLS
EP1745145A4 (en) 2004-05-11 2008-03-26 Heptest Lab Inc COMPOSITIONS, KIT AND METHOD IN ONE STEP FOR MONITORING COMPOUNDS HAVING XA AND / OR ANTIFACTOR IIA ANTIFACTOR ACTIVITIES
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
EP1907841B1 (en) * 2005-06-22 2009-08-05 The Johns Hopkins University Biomarker for ovarian cancer: ctap3-related proteins
US20070059774A1 (en) 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
AU2006292394A1 (en) 2005-09-15 2007-03-29 Artemis Health, Inc. Systems and methods for enrichment of analytes
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20100297621A1 (en) * 2007-06-20 2010-11-25 University Of Utah Research Foundation Use of pre-mrna splicing in platelet cells for the diagnosis of disease
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP2336353A1 (en) 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
MX351242B (es) 2010-07-16 2017-10-05 Stichting Vu Vumc Star Un metodo para analizar una muestra de sangre de un sujeto por la presencia de un marcador de enfermedad.
CA2830461C (en) 2011-03-18 2021-06-29 Thomas Wurdinger A method of analysing a blood sample of a subject for the presence of a disease marker
EP3444360A1 (en) 2011-08-09 2019-02-20 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg A method of analysing a blood sample of a subject for the presence of a foetal disease or condition marker

Also Published As

Publication number Publication date
CA2805586A1 (en) 2012-01-19
JP6171057B2 (ja) 2017-07-26
AU2011277178A1 (en) 2013-01-31
AU2011277178B2 (en) 2016-10-20
MX2013000606A (es) 2013-06-28
EP2593787A2 (en) 2013-05-22
MX351242B (es) 2017-10-05
SG187101A1 (en) 2013-02-28
JP2013534429A (ja) 2013-09-05
BR112013001136B1 (pt) 2020-12-15
BR112013001136A2 (pt) 2016-07-05
EP2593787B1 (en) 2018-07-04
CA2805586C (en) 2020-09-01
WO2012008839A2 (en) 2012-01-19
CN103168235B (zh) 2016-01-13
CN103168235A (zh) 2013-06-19
JP2017018099A (ja) 2017-01-26
US10174364B2 (en) 2019-01-08
WO2012008839A3 (en) 2012-03-01
JP6076901B2 (ja) 2017-02-15
AU2011277178A2 (en) 2013-02-07
WO2012008839A9 (en) 2012-05-03
US20130196873A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
HK1186767A1 (zh) 用於分析受試者血樣中疾病標記物的存在的方法
PL2579782T3 (pl) Narzędzie do pobierania próbki tkanki zwierzęcej
EP2613138A4 (en) PROCESS FOR DETECTION OF BIOLOGICAL SUBSTANCES
ZA201300435B (en) Apparatus for disease detection
EP2572334A4 (en) Image analysis for making animal measurements
EP2712299A4 (en) METHODS AND ARRANGEMENTS FOR OBTAINING INFORMATION AND PROVIDING ANALYSIS FOR BIOLOGICAL TISSUES
IL222463B (en) A non-invasive method for measuring glucose
BR112013032816A2 (pt) método para a análise de espécimes biológicos através de imagem espectral
IL223853A (en) A method for analyzing biological findings using spectral imaging
EP2538839A4 (en) METHOD FOR ANALYZING A MEDICAL IMAGE
EP2475791A4 (en) ANALYSIS OF Y-CHROMOSOME STR MARKERS
IT1393218B1 (it) Apparecchiatura per analizzare un campione biologico
EP2389573A4 (en) SKIN ANALYSIS PROCEDURE
EP2596117A4 (en) METHOD FOR DETECTING NIERGENICAL DISEASES OR SUFFERING
EP2615975A4 (en) METHOD FOR NON-INVASIVE ANALYSIS OF THE CONCENTRATION OF A SUBSTANCE IN AN ORGANISM
HK1184990A1 (zh) 抽出血樣
SG175784A1 (en) On-chip laboratory for blood analysis
EP2561350A4 (en) METHOD AND SYSTEM FOR ANALYZING A BLOOD TEST
EP2587265A4 (en) METHOD FOR DETERMINING OR EVALUATING A SUBSTANCE OF INTEREST
IL231982A0 (en) A method for the diagnosis of Niemann-Pick disease
ZA201302402B (en) Methods for diagnosing lyme disease
EP2530468B8 (en) METHOD OF ANALYZING HUMAN sCD14-ST
PL2757952T3 (pl) Pobieranie próbki krwi
GB2500548B (en) Trenched sample assembly for detection of analytes
HK1184989A1 (zh) 血樣收集

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210713